Myeloproliferative Neoplasms Clinical Trial

Phase IV EORTC Quality of Life Module for Patients With Chronic Myeloid Leukemia

Summary

The objective of this study is to test the scale structure, reliability, validity and responsiveness to change of the QLQ-leukemia-cml/" >CML24 in conjuction with the QLQ-C30 for patients diagnosed with CML, and to investigate longitudinal relationship between satisfaction with information provision and QoL outcomes.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Above 18 years of age.
Patient with confirmed diagnosis of Philadelphia chromosome positive and/or BCR-ABL positive chronic myeloid leukemia (CML).
Written informed consent.
Patients enrolled in investigational drug-trials or other type of clinical trials are also eligible.

Exclusion Criteria:

Patients with a psychiatric condition or major cognitive impairment (as evaluated by their treating physician) that would hinder completion of self-reported health-related QoL questionnaires.
Patients who are unable to speak and read the language of the questionnaire.

Study is for people with:

Myeloproliferative Neoplasms

Estimated Enrollment:

337

Study ID:

NCT03075969

Recruitment Status:

Unknown status

Sponsor:

Gruppo Italiano Malattie EMatologiche dell'Adulto

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 4 Locations for this study

See Locations Near You

Winship Cancer Institute of Emory University
Emory Georgia, 30322, United States
Innsbruck Medical University
Innsbruck , , Austria
Complexo Hospital de Clinicas da Universidade Federal do Parana
Paranã , , Brazil
Guangdong Medical University
Guangdong , , China
Universität Heidelberg
Heidelberg , , Germany
Baghdad Teaching Hospital
Baghdad , , Iraq
Azienda Ospedaliero - Universitaria Ospedali Riuniti Umberto I - G.M. Lancisi - G. Salesi
Ancona , , Italy
Azienda Ospedaliero-Universitaria Policlinico Consorziale
Bari , , Italy
Department of Oncology and Hematology, O.U. of Hematology, S. Orsola-Malpighi University Hospital, Bologna
Bologna , , Italy
Sezione di Ematologia e Trapianti Spedali Civili
Brescia , 21125, Italy
CTMO - Ematologia - Ospedale Binaghi
Cagliari , , Italy
Divisione clinicizzata di Ematologia - Dipartimento di Scienze Mediche - Osp. Ferrarotto
Catania , , Italy
Clinica Ematologica - Dipartimento di Medicina Interna - IRCCS San Martino - IST
Genova , , Italy
Lecce ASL Le/1 P.O. Vito Fazzi - U.O. di Ematologia ed UTIE
Lecce , , Italy
U.O. Ematologia 1 - Centro Trapianti di Midollo - Ospedale Maggiore Milano
Milano , , Italy
Divisione di Ematologia - Dip. Di Medicina Clinica e Sperimentale & BRMA - Università Piemonte Orientale "Amedeo Avogato"
Novara , , Italy
Azienda Ospedaliera Universitaria - Policlinico Paolo Giaccone
Palermo , , Italy
U.O.C. di Ematologia e CTMO Az. Ospedaliero Universitaria Parma
Parma , , Italy
Div. di Ematologia IRCCS Policlinico S. Matteo
Pavia , 27100, Italy
Dipartimento di Oncologia ed Ematologia - AUSL Ospedale G. da Saliceto
Piacenza , , Italy
Dipartimento Oncologico - Ospedale S.Maria delle Croci
Ravenna , , Italy
Unità Operativa Complessa di Ematologia - Arcispedale S. Maria Nuova
Reggio Emilia , , Italy
Clinica di Ematologia - Policlinico Umberto I- Università degli Studi "Sapienza"
Roma , , Italy
Divisione di Ematologia - Ospedale S.Eugenio
Roma , , Italy
Divisione Ematologia - Università Campus Bio-Medico
Roma , , Italy
Università Cattolica del Sacro Cuore - Policlinico A. Gemelli
Roma , , Italy
U.O. di Ematologia - Casa Sollievo della Sofferenza
San Giovanni Rotondo , , Italy
Ematologia - AOU Sassari
Sassari , , Italy
U.O di Ematologia d. U. - Azienda Ospedaliera Universitaria Integrata Verona
Verona , , Italy
Ospedale San Bortolo
Vicenza , 36100, Italy
UCSI University, Faculty of Pharmaceutical Sciences
Kuala Lumpur , , Malaysia
Eindhoven and Tilburg University
Eindhoven , , Netherlands

How clear is this clinincal trial information?

Study is for people with:

Myeloproliferative Neoplasms

Estimated Enrollment:

337

Study ID:

NCT03075969

Recruitment Status:

Unknown status

Sponsor:


Gruppo Italiano Malattie EMatologiche dell'Adulto

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider